These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 423090)

  • 1. Synthesis and therapeutic testing of mono- and dialkyl esters of pentetic (diethylenetriaminepentaacetic) acid for decorporation of polymeric plutonium.
    Guilmette RA; Parks JE; Lindenbaum A
    J Pharm Sci; 1979 Feb; 68(2):194-6. PubMed ID: 423090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DTPA-Coated Liposomes as a New Delivery Vehicle for Plutonium Decorporation.
    Grémy O; Mougin-Degraef M; Devilliers K; Berdal M; Laroche P; Miccoli L
    Radiat Res; 2021 Jan; 195(1):77-92. PubMed ID: 33180911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
    Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
    Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decorporation of monomeric plutonium from the dog by glucan and-or DTPA.
    Baxter DW; Rosenthal MW; Lindenbaum A
    Radiat Res; 1973 Jul; 55(1):144-52. PubMed ID: 4716888
    [No Abstract]   [Full Text] [Related]  

  • 5. [239Pu distribution in bone tissue elements and the effects of DTPA on this process].
    Levdik TI; Iashunskiĭ VG; Samoĭlova OI
    Med Radiol (Mosk); 1976 Aug; 21(8):39-45. PubMed ID: 1018628
    [No Abstract]   [Full Text] [Related]  

  • 6. Effective dose of DTPA, spaced at 3 day intervals, in removal of skeletal plutonium.
    Rosenthal MW; Russell JJ; Moretti ES; Lindenbaum A
    Health Phys; 1969 Jun; 16(6):806-8. PubMed ID: 5795281
    [No Abstract]   [Full Text] [Related]  

  • 7. Removal of plutonium from mouse liver by glucan and DTPA.
    Rosenthal MW; Brown H; Chladek DL; Moretti ES; Russell JJ; Lindenbaum A
    Radiat Res; 1973 Jan; 53(1):102-14. PubMed ID: 4568226
    [No Abstract]   [Full Text] [Related]  

  • 8. Removal of polymeric plutonium from dogs with DTPA and glucan.
    Rosenthal MW; Lindenbaum A; Baxter DW; Kalesperis GS; Moretti ES; Russell JJ
    Radiat Res; 1975 Aug; 63(2):253-61. PubMed ID: 1096228
    [No Abstract]   [Full Text] [Related]  

  • 9. Decorporation Approach after Rat Lung Contamination with Plutonium: Evaluation of the Key Parameters Influencing the Efficacy of a Protracted Chelation Treatment.
    Grémy O; Coudert S; Renault D; Miccoli L
    Radiat Res; 2017 Nov; 188(5):552-561. PubMed ID: 28945525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacies of LICAM(C) and DTPA for the decorporation of inhaled transportable forms of plutonium and americium from the rat.
    Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A
    Hum Toxicol; 1986 Mar; 5(2):77-84. PubMed ID: 3514430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I.
    Guilmette RA; Moretti ES; Lindenbaum A
    Radiat Res; 1979 Jun; 78(3):415-28. PubMed ID: 221958
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of DTPA on hepatic plutonium. II. DTPA-induced removal of monomeric plutonium from mouse liver parenchymal cells.
    Bhattacharyya MH; Peterson DP; Lindenbaum A
    Radiat Res; 1978 Oct; 76(1):180-6. PubMed ID: 734044
    [No Abstract]   [Full Text] [Related]  

  • 13. Decorporation approach following rat lung contamination with a moderately soluble compound of plutonium using local and systemic Ca-DTPA combined chelation.
    Grémy O; Tsapis N; Bruel S; Renault D; Van der Meeren A
    Radiat Res; 2012 Sep; 178(3):217-23. PubMed ID: 22799632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of polymeric plutonium by DTPA directed into cells by liposome encapsulation.
    Rosenthal MW; Rahman YE; Moretti ES; Cerny EA
    Radiat Res; 1975 Aug; 63(2):262-74. PubMed ID: 1144691
    [No Abstract]   [Full Text] [Related]  

  • 15. Dependency of chelation efficacy upon time after first DTPA injection.
    Lloyd RD; Taylor GN; Mays CW; Jones CW; Bruenger FW; Atherton DR
    Radiat Res; 1979 Jun; 78(3):448-54. PubMed ID: 451166
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of skeletal plutonium levels based on DPTA-induced radionuclide excretion in feces: possible application to man.
    Bhattacharyya MH; Guilmette RA; Peterson DP; Chao FC; Lindinbaum A
    Health Phys; 1978 Jun; 34(6):549-55. PubMed ID: 730507
    [No Abstract]   [Full Text] [Related]  

  • 17. [A comparative evaluation of the efficacy of different methods for the decorporation of plutonium from the respiratory organs].
    Liubchanskiĭ ER; Sokhranich AL; Sokol'nikov ME
    Radiats Biol Radioecol; 1997; 37(1):105-10. PubMed ID: 9102121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations into techniques for removing intracellular plutonium-III.
    Bulman RA; Griffin RJ
    Naturwissenschaften; 1981 Sep; 68(9):483-5. PubMed ID: 7290218
    [No Abstract]   [Full Text] [Related]  

  • 19. Whole-body autoradiographic studies on plutonium metabolism as affected by its physico-chemical state and route of administration.
    Matsuoka O; Kashima M; Joshima H; Noda Y
    Health Phys; 1972 Jun; 22(6):713-22. PubMed ID: 5084002
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic and therapeutic studies of plutonium. IV. ANL-7535.
    Lindenbaum A; Rosenthal MW; Lund CJ; Russell JJ; Smoler MH; Moretti ES; Brown H
    ANL Rep; 1968 Dec; ():60-5. PubMed ID: 5306872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.